Skip to content

Prestige Consumer Healthcare

US · PBH #2733 by market cap Listed 1970
47.57 +1.13 +2.43%
Live - 5344 symbols - heartbeat 498s ago · 2026-10-07 19:54
After-hours 47.57 0.00%
Market cap
2.25B
P/B
1.18
EPS
3.91
Reader sentiment Are you bullish or bearish on PBH?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72
    Market Newswire · 2025/10/21
  • Analysts Offer Insights on NA Companies: Springer Nature AG & Co. KGaA (OtherSPGDF) and Prestige Consumer Healthcare (PBH)
    TipRanks · 2026/8/6
  • Rating change
    Jefferies Maintains Prestige Consumer Healthcare(PBH.US) With Hold Rating, Cuts Target Price to $71
    Market Newswire · 2025/10/27
  • Rating change
    RBC Capital Initiates Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $129
    Market Newswire · 2026/3/20
  • Rating change
    Research Alert: Pbh Q1: Revenue Up 25% To Cad2.1b On Stampede Deal; Maintains 2026 Guidance
    MT Newswires · 2026/5/7
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $86
    Market Newswire · 2026/3/23
  • Rating change
    Jefferies Maintains Prestige Consumer Healthcare(PBH.US) With Hold Rating, Cuts Target Price to $66
    Market Newswire · 2026/1/31
  • Rating change
    Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $77
    Market Newswire · 2026/2/11
  • William Blair Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
    Market Newswire · 2026/8/6
  • Rating change
    Oppenheimer Downgrades Prestige Consumer Healthcare(PBH.US) to Hold Rating
    Market Newswire · 2026/5/14
  • CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $72
    Market Newswire · 2026/8/8
  • Rating change
    Sidoti Upgrades Prestige Consumer Healthcare(PBH.US) to Buy Rating, Cuts Target Price to $80
    Market Newswire · 2025/9/24
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $72
    Market Newswire · 2026/5/15
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $88
    Market Newswire · 2025/11/7
  • Rating change
    Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Announces Target Price $65
    Market Newswire · 2026/5/7
  • Rating change
    Oppenheimer Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating
    Market Newswire · 2026/2/24
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Cuts Target Price to $86
    Market Newswire · 2026/2/6
  • Rating change
    CCORF Maintains Prestige Consumer Healthcare(PBH.US) With Buy Rating, Maintains Target Price $88
    Market Newswire · 2026/1/14
  • Prestige Consumer Healthcare Inc. (PBH) Clear Eyes and Pillar5 Problems Drive Stock Lower, HBSS Investigating
    PR Newswire · 2026/6/25
  • Premium Brands Holdings: Board Approves NCIB for Repurchase of Up to 1M Common Shares PBH.T
    Dow Jones · 2026/10/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.